Antibiotic Coated Nail for Preventing Infection in Broken Bones
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests whether an antibiotic-coated nail can better prevent infections in people with open tibia fractures compared to a standard nail. Researchers aim to determine if adding antibiotics to the nail reduces infections after surgery. The trial involves two treatment plans: one group receives the antibiotic-coated nail, while the other receives the standard nail. People with open tibia fractures requiring an intramedullary nail for bone repair may be suitable candidates, particularly those with severe breaks that pierce the skin (Type II or III open fractures). As a Phase 4 trial, this research seeks to understand how the already FDA-approved and effective treatment can benefit more patients.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications.
What is the safety track record for these treatments?
Research has shown that antibiotic-coated intramedullary nails are generally safe for humans. Coated with antibiotics such as vancomycin and gentamicin, these nails effectively control infections. One study managed infections without recurrence, indicating the treatment's reliability in preventing infections.
Furthermore, studies have not identified any significant side effects from using these nails. They have successfully treated fractures and cases where broken bones did not heal properly. Participants in these studies did not experience major negative reactions to the antibiotics in the coating.
Overall, these findings suggest that antibiotic-coated nails are well-tolerated and safe for treating bone infections.12345Why are researchers enthusiastic about this study treatment?
Researchers are excited about the antibiotic coated intramedullary nail because it offers a new way to prevent infections in broken bones. Unlike the standard treatment that uses a plain intramedullary nail, this innovative nail is coated with antibiotics like vancomycin and gentamicin. This coating actively fights bacteria, potentially reducing the risk of infection right at the site of the fracture. By directly delivering antibiotics where they're needed most, this approach could offer better protection against infections compared to traditional methods.
What evidence suggests that this trial's treatments could be effective for preventing infection in broken bones?
Research has shown that antibiotic-coated nails, a treatment under study in this trial, effectively prevent infections in broken bones. Studies have found a high success rate of 93.3% in stopping infections and 90.0% in aiding proper bone healing. These nails are coated with antibiotics like vancomycin and gentamicin, which target infections directly at the break site without causing side effects elsewhere in the body. This method has successfully treated infections in long bones, such as the femur and tibia, promoting proper healing. Overall, this treatment has demonstrated strong results in both preventing infections and promoting bone healing. Participants in this trial may receive either the antibiotic-coated nails or standard intramedullary nails to compare their effectiveness.12567
Who Is on the Research Team?
Joseph Hsu, MD
Principal Investigator
Wake Forest University Health Sciences
Are You a Good Fit for This Trial?
This trial is for adults with a type II or III open tibia fracture needing a nail implant to fix the bone. Participants must be able to follow up for a year and speak English or Spanish. It's not for those under 18, allergic to vancomycin/gentamicin, pregnant/lactating women, prisoners, or unable to commit.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either a prophylactic antibiotic coated intramedullary nail or a traditional standard of care intramedullary nail during definitive fixation
Follow-up
Participants are monitored for safety and effectiveness after treatment, with data capture at baseline, 6 weeks, 3 months, 6 months, and 12 months
What Are the Treatments Tested in This Trial?
Interventions
- Antibiotic coated intramedullary Nail
- Standard Intramedullary Nail
Antibiotic coated intramedullary Nail is already approved in India for the following indications:
Find a Clinic Near You
Who Is Running the Clinical Trial?
Wake Forest University Health Sciences
Lead Sponsor